晚期非小细胞肺癌化疗患者的焦虑抑郁状态评估及护理干预效果

Evaluation of the status of anxiety,depression and effect observation of nursing intervention on advanced non-small cell lung cancer patients treated with chemotherapy

目的探讨晚期非小细胞肺癌化疗患者的焦虑、抑郁状态评估及护理干预效果。方法选择我院2010年1月至2012年7月收治的81例晚期非小细胞肺癌化疗患者,按照随机数字表法分为两组,对照组40例采用常规化疗护理方法,观察组41例加强心理护理干预,比较分析两组患者的心理状态、生活质量改善情况。结果采用Zung焦虑量表(SAS)、抑郁量表(SDS)评定患者心理状态显示,护理前SAS、SDS评分组间差异无统计学意义(P>0.05),护理后观察组SAS、SDS评分均明显优于对照组(P<0.05);采用诺丁汉健康调查问卷(NHP)对两组患者的生活质量进行评价,护理前NHP评分组间差异无统计学意义(P>0.05),护理后观察组患者的NHP评分明显优于对照组,组间差异有统计学意义(P<0.05)。结论对晚期非小细胞肺癌化疗患者的焦虑、抑郁状态进行评估并加强针对性的心理护理干预,可以明显改善患者的心理状态及生活质量,提高晚期非小细胞肺癌化疗患者的生存质量。

Objective To analyze the evaluation of the status of anxiety,depression and effect observation of nursing intervention on advanced non-small cell lung cancer patients treated with chemotherapy.Methods From January 2010 to July 2012 in our hospital,81 patients with advanced non-small cell lung cancer treated by chemotherapy were selected and randomly divided into two groups,the control group（40 cases）adopted by conventional nursing,the observation group（41 cases）adopted psychological nursing intervention on the basis of control group,the psychological state and quality of life of two groups were compared and analyzed.Results The psychological state of patients were assessed by Zung Anxiety Scale（SAS）and depression scale（SDS）,before nursing,the SAS and SDS score of two groups showed no significant difference（P0.05）,after nursing the SAS and SDS scores of observation group were significantly better than the control group（P0.05）;the quality of life evaluation of patients were assessed by Nottingham Health Survey（NHP）,before nursing,the SAS and SDS score of two groups showed no significant difference（P0.05）,after nursing the NHP scores of observation group were significantly better than the control group（P0.05）.Conclusions Evaluation of the status of anxiety,depression of advanced non-small cell lung cancer patients and strengthen psychological nursing intervention can significantly improve the patient＇s psychological status and quality of life,improve the living quality of advanced non-small cell lung cancer patients treated with chemotherapy.